Chronic exposure to EBV antigens leads to sustained PD-1 expression on tumor-infiltrating lymphocytes and upregulated programmed death ligand 1 (PD-L1) expression on tumor and stromal cells, particularly in nonkeratinizing subtypes of NPC. The gene discussed is PDCD1; the disease is nasopharyngeal carcinoma.